German company Jan Medical, which is located in Mountain View, California, has raised $ 7.5 million recently from Brainlab Company for the research and development expenditure of diagnostic equipment for neurological diseases. The device will help to detect concussion, stroke and other neurological diseases. It is reported that so far, Jan medical has funding at least $ 10.6 million on the project. The company will use the funds to complete the initial application for a variety of clinical trials, FDA approval and CE certification registration.
Jan Medical CEO Paul Lovoi's wife, named Jan, died of subarachnoid hemorrhage stroke. After his wife's death, Lovoi established this medical company and named the company after his wife's name.
"About the stroke, I understand a lot. I set up this company in order to develop a better way to determine cerebral vascular lesions instead of catheterization laboratory and angiography, Lovoi tells the Mobi Health News. "This is my original intention of the establishment of this medical company."
Although Lovoi had already started work at the company from 2003, he left midway. It was not until 2008 did he returned to the company for full-time work.
The diagnostic equipment developed by Jan medical is called Nautilus BrainPulse 1100, which is composed of a headset, data collector, battery and touch-screen computer and other components. There are two sensors on the headset - one for detecting heart rate, and the other one for detecting ambient noise. Besides, there are six accelerometers on the headset used to determine the head impact acceleration. Diagnostic test consists in the neurological intensive care nurse in charge of the emergency department, only three minutes, will be able to complete the test.
Lovoi said that although at present the diagnostic device has been able to connect with a laptop computer, his ultimate plan is to synchronize the headset and tablet PCs, and the data stored in the cloud.
The effect of the diagnostic equipment for the use of, Jan medical company has been doing experimental research, in which the most important is related to a concussion. The company plans to recruit 600-800 or very likely to suffer a concussion or not susceptible to concussions people to complete the test, and relatively easy to suffer concussion through the crowd and the crowd is not easy to suffer a concussion BrainPulse readings Evaluation of the effectiveness of Nautilus BrainPulse diagnosis of brain concussion.
The company plans to apply for the permissions of Nautilus BrainPulse's accuracy and security when detecting brain pulses, then the certification related to neural spasm, ischemic stroke and brain concussion.
Recommended content: http://www.cusabio.com/Recombinant-Protein/Recombinant-Saccharomyces-cerevisiae-strain-ATCC-204508--S288c-Bakers-yeast-Exopolyphosphatase-11106394.html
没有评论:
发表评论